Eddie Yongming Wu - 18 Mar 2026 Form 3 Insider Report for Alibaba Group Holding Ltd (BABA)

Role
Chief Executive Officer, Director
Signature
/s/ Kevin Jinwei Zhang, as Attorney-in-Fact for Eddie Yongming Wu
Issuer symbol
BABA
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 08:11:12 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wu Yongming Chief Executive Officer, Director 26/F TOWER ONE, TIMES SQUARE, 1 MATHESON STREET, CAUSEWAY BAY, HONG KONG, HONG KONG /s/ Kevin Jinwei Zhang, as Attorney-in-Fact for Eddie Yongming Wu 18 Mar 2026 0002121606

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BABA Ordinary Shares 959,752 18 Mar 2026 Direct
holding BABA Ordinary Shares 108,000 18 Mar 2026 By spouse
holding BABA Ordinary Shares 12,320,000 18 Mar 2026 By trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BABA Restricted Shares Units 18 Mar 2026 Ordinary Shares 960,000 Direct F1, F2
holding BABA Restricted Shares Units 18 Mar 2026 Ordinary Shares 280,000 Direct F3, F4
holding BABA Option (right to buy) 18 Mar 2026 Ordinary Shares 16,000,000 Direct F5, F6
holding BABA Option (right to buy) 18 Mar 2026 Ordinary Shares 12,000,000 Direct F7, F8
holding BABA Option (right to buy) 18 Mar 2026 Ordinary Shares 12,000,000 Direct F9, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the outstanding unvested portion of a restricted share unit award granted in the form of American Depository Shares ("ADSs") that vests in five equal annual installments beginning on Sep 10, 2024, subject to the terms and conditions of the underlying award agreement.
F2 Each restricted share unit represents a contingent right to receive one ADS. Each ADS represents 8 ordinary shares. This amount represents the ordinary shares underlying the ADSs in this award.
F3 Reflects the outstanding unvested portion of a restricted share unit award granted in the form of ordinary shares that vests in twenty-four equal quarterly installments beginning on Jul 1, 2025, subject to the terms and conditions of the underlying award agreement.
F4 Each restricted share unit represents a contingent right to receive one ordinary share.
F5 Reflects an option award granted in the form of ADSs that vests in five equal annual installments beginning Sep 10, 2024, subject to the terms and conditions of the underlying award agreement. This amount represents the ordinary shares underlying the ADSs in this award.
F6 The exercise price of this option US$78.37 per ADS.
F7 Reflects an option award granted in the form of ordinary shares that vests in three equal annual installments beginning on Nov 26, 2026, subject to the terms and conditions of the underlying award agreement.
F8 The exercise price of this option is HK$116.70 per share. The exercise price reported herein was converted from Hong Kong dollars to United States dollars at a conversion price of HK$116.70 to US$14.96.
F9 Reflects an option award granted in the form of ordinary shares that vests in three equal annual installments beginning on Nov 26, 2029, subject to the terms and conditions of the underlying award agreement.
F10 The exercise price of this option is HK$152.69 per share. The exercise price reported herein was converted from Hong Kong dollars to United States dollars at a conversion price of HK$152.69 to US$19.58.